Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Contraception|July 24, 2023
Bleeding profile and safety of a levonorgestrel 13.5 mg intrauterine device versus Nova T copper 380 mm2 intrauterine device: Results of a 3-year, single-center, randomized phase 4 studyJosep Perelló-Capó, Josep Estadella-Tarriel, Ignasi Gich-Saladich, et al.The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|September 27, 2016
Pregnancy beyond 65: report of a unique case and discussion of a controversial issueMarta Simó González, Joaquim Calaf Alsina, Núria Terribas Sala, et al.Menopause (New York, N.Y.)|December 19, 2008
Raloxifene use in clinical practice: efficacy and safetySteven R Goldstein, Claire S Duvernoy, Joaquim Calaf, et al.International Journal of Fertility & Sterility|April 9, 2025
Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I StudyAgnes Arbat, Ignasi Canals, Jimena Coimbra, et al.The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|January 18, 2022
The global pandemic and changes in women's reproductive health: an observational studyLiya Haile, Niels van de Roemer, Kristina Gemzell-Danielsson, et al.Women & Health|June 8, 2023
The HOPE study: evaluating the impact of an online educational resource for heavy menstrual bleeding on the patient-physician dynamicAgnaldo Lopes Silva Filho, William H Catherino, Jean-Philippe Estrade, et al.Maturitas|March 21, 2026
Safety of vaginal estrogen in breast cancer survivors: Current evidence on systemic absorption and oncologic outcomesLaura Baquedano Mainar, Laura Nieto-Pascual, Eva Iglesias Bravo, et al.BJOG : an International Journal of Obstetrics and Gynaecology|December 11, 2003
Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trialJoaquim Calaf Alsina, José A Ruiz Balda, Alberto Romeu Sarrió, et al.Neuromuscular Disorders : NMD|January 4, 2011
Ultrasound evaluation of fetal movements in pregnancies at risk for severe spinal muscular atrophyJuan Parra, Rebeca Martínez-Hernández, Eva Also-Rallo, et al.Journal of Women'S Health (2002)|June 26, 2020
Development and Psychometric Validation of a Screening Questionnaire to Detect Excessive Menstrual Blood Loss That Interferes in Quality of Life: The SAMANTA QuestionnaireJoaquim Calaf, María Jesús Cancelo, Mercedes Andeyro, et al.Pageof 5